Thymosin beta-4

Regenerative

Wound repair, angiogenesis and tissue remodeling signals

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: Actin binding/cell migration
Primary market use: Wound healing / recovery

Pharmacology

Molecular weight (Da): ~4963.5
Oral bioavailability: N/A
Half-life: ~2 h; not well established
Route tags: Route-dependent / verify
Evidence level: Clinical/Preclinical
Clinical status: Investigational
Value-for-money score: 6 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Parent molecule for TB-500 positioning

Sources

https://pubmed.ncbi.nlm.nih.gov/